Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Jack Zhang
CONTACT
Bohong Zhang
CONTACT
Lead
InxMed (Shanghai) Co., Ltd.
Study will evaluate IN10018 in combination with pegylated liposomal doxorubicin (PLD) in subjects with platinum-resistant recurrent ovarian cancer. All the subjects will receive combination therapy until documented progressive disease or unacceptable toxicity.
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted